TNAP promotes cardiac fibrosis post-MI by activating TGF-β1/Smads and ERK1/2 pathways, leading to fibroblast differentiation, migration, and excessive collagen deposition, which impairs cardiac function. The gene discussed is ALPL; the disease is myocardial infarction.